ResMed Inc. (Premium)



Ticker code: ASX:RMS

ASX:RMS Red Flags & Risk Indicators
⚠️ RED FLAGS: 0 identified

No red flags detected.

Income Statement
Revenue 2024 Per Share Revenue 2025e Per Share Revenue 2026e Per Share Revenue 24 to 25e [%] Revenue 25e to 26e [%] EBITDA 2024 Per Share EBITDA 2025e Per Share EBITDA 2026e Per Share EBITDA 24 to 25e [%] EBITDA 25e to 26e [%]
0.77638 0.62002 0.49745 -20.1 -19.8 0.40659 0.66251 0.32009 62.9 -51.7
ASX:RMS Revenue Per Share (2012–2027)
ResMed Inc. (ASX:RMS) Revenue Chart 2012–2027
ASX:RMS Earnings before Interest, Tax, Depreciation and Amortisation (EBITDA) Per Share (2012–2027)
✅✅
ResMed Inc. (ASX:RMS) EBITDA Chart 2012–2027
ASX:RMS Normalised Earnings Per Share (EPS) (2012–2027)
✅✅
ResMed Inc. (ASX:RMS) Normalised EPS Chart (2012–2027)

Valuation
Price To Sales Price To Book PER 2023 PER 2024 13Y Median PER Low PER 2025e 13Y Median PER High PER 2026e Last Updated
5.5 2.1 43.0 19.1 7.1 11.1 15.4 11.9 23/7/25
ASX:RMS Yearly Price Earnings Ratio (PER) Highs and Lows
ResMed Inc. (ASX:RMS) PER Highs and Lows (2012–2027)
ASX:RMS Weekly Price Chart with Average True Range (ATR) Trailing Stop (10-Year View)
ResMed Inc. (ASX:RMS) 10-Year Weekly ATR Trailing Stop Price Chart


Leave a Reply

Your email address will not be published. Required fields are marked *